PET/CT assessment of tumor perfusion (TP) in metastatic renal cell cancer (RCC) patients (pts) on sunitinib (S) using 62Cu-ETS.

Theodore F. Logan,James W. Fletcher,Mark A. Green,Jacob A. Eitel,Sandra Althouse,Susan M. Perkins,Gary D. Hutchins

PET/CT assessment of tumor perfusion (TP) in metastatic renal cell cancer (RCC) patients (pts) on sunitinib (S) using 62Cu-ETS.

2018

Theodore F. Logan
James W. Fletcher
Mark A. Green
Jacob A. Eitel
Sandra Althouse
Susan M. Perkins
Gary D. Hutchins

e16567Background: Assessment of TP using 62Cu-ETS PET/CT has been demonstrated in pts with RCC (Fletcher et al, J Nuc Med 2015; 56:56-62, Logan et al, ASCO 2014; abstr 11110) compared to 15O-water ...

Keywords:

Metastatic renal cell cancer
Oncology
Pathology
PET-CT
Internal medicine
Medicine
Perfusion
Sunitinib
tumor perfusion

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations